토피라메이트에 의해 발생한 급성 근시 2예 = Two Cases of Topiramate-induced Acute Myopia

다국어 초록 (Multilingual Abstract)

Purpose: We describe 2 cases of bilateral acute myopia associated with topiramate, a drug that has recently been prescribed for epilepsy or weight reduction. Case summary: A 24-year-old woman and a 25-year-old woman, both previously devoid of ocular problems, visited our hospital with blurry vision after taking topiramate for weight reduction. A thorough medical history review and ocular examinations, including a slit lamp examination, were performed. Conclusions: Slit-lamp examinations revealed forward displacement of the lens-iris diaphragm, which resulted in myopia and anterior chamber shallowing. Discontinuation of topiramate and the administration of cycloplegic agents successfully resolved the symptoms. J Korean Ophthalmol Soc 49(6):1033-1040, 2008

참고문헌 (Reference)

1 Sankar PS, "Uveal effusion and secondary angle‐closure glaucoma associated with topiramate use" 119 : 1210-1211, 2001

2 Hook SR, "Transient myopia induced by sulfonamides" 101 : 495-496, 1986

3 Sen HA, "Topiramate‐induced acute myopia and retinal striae" 119 : 775-777, 2001

4 Jeon C, "Topiramate‐induced Acute Angle‐Closure Glaucoma" 46 : 1944-1950, 2005

5 Privitera M, "Topiramate placebo- controlled close-ranging trial in refractory partial epilepsy using 600, 800, and 1000 mg daily dosages" 46 : 1678-1683, 1996

6 Thambi L, "Topiramate associated secondary angle‐closure glaucoma: a case series" 120 : 1108-, 2002

7 Fraunfelder FW, "Topiramate associated acute bilateral secondary angle‐closure glaucoma" 111 : 109-111, 2004

8 Gubbay SS, "The occurrence of drug‐induced myopia as a transient side effect of topiramate" 39 : 451-, 1998

9 Bovino JA, "The mechanism of transient myopia induced by sulfonamide therapy" 94 : 99-101, 1982

10 Richard D, "The effect of topiramate and sex hormones on energy balance of male and female rats" 26 : 344-353, 2002

11 Kockelmann E, "Significant improvement in frontal lobe associated neuropsychological function after withdrawal of topiramate in epilepsy patients" 54 : 171-178, 2003

12 Gryder DS, "Selective antagonism of GluR5 Kainate‐receptor mediated synaptic currents by topiramate in rat basolateral amygdale neurons" 18 : 7069-7074, 2003

13 Banta JT, "Presumed topiramate- induced bilateral acute angle‐closure glaucoma" 132 : 112-114, 2001

14 Tatum WO, "Postmarketing experience with topiramate and cognition" 42 : 1134-1140, 2001

15 Ziemann U, "Phamacology of TMS" 56 : 226-231, 2003

16 Bourgeois BF, "Phamacokinetics and pharmacodynamics of topiramate" 15 : 27-30, 2000

17 Craig JE, "Mechanism of topiramate‐induced acute‐onset myopia and angle closure glaucoma" 137 : 193-195, 2004

18 Richard D, "Influence of topiramate in the regulation of energy balance" 16 : 961-966, 2000

19 Krieg PH, "Drug induced ciliary body oedema:a new theory" 10 : 121-126, 1996

20 Rhee DJ, "Bilateral angle‐closure glaucoma and ciliary body swelling from topiramate" 119 : 1721-1723, 2001

21 Medeiros FA, "Angle closure glaucoma associated with ciliary body detachment in patients using topiramate" 121 : 282-285, 2003